EMS-Chemie Boosts Profitability with Strong First-Half 2026 Results

EMS-Chemie reported its first-half 2026 results on August 28, 2026, highlighting a significant improvement in profitability despite a slight decline in revenue. The company's EBIT margin expanded to 30.60 percent, up from 29.10 percent a year earlier. Net sales, however, dipped 0.98 percent to CHF 1.01 billion, compared to CHF 1.02 billion in the same period of 2025.

Profitability metrics showed positive trends, with EBIT increasing 4.39 percent to CHF 309.00 million and net income rising 2.37 percent to CHF 259.00 million. The company attributed these gains to its focus on high-margin specialties, innovation, and new business, which offset challenges like a weak industrial economy, geopolitical pressures, and a stronger Swiss franc.

EMS-Chemie's EBITDA also improved, climbing 3.40 percent to CHF 335.00 million. The stock traded at EUR 897.75 on October 5, 2026, at 1:29 p.m. CEST, down slightly from the prior close of EUR 898.00. The company's highest 52-week price was CHF 839.50 on August 10, 2026, with the recent trading levels showing minimal deviation from this peak.

The company's specialty chemicals and high-performance polymers continue to support its operating leverage, making profitability metrics more significant for investors than the slight revenue decline. The stock's performance reflects these underlying trends, with investors likely focusing on the margin expansion and future sales trends.